Process Chemistry

Oligonucleotide Synthesis

Support for modified monomers, supports, sulfurizing reagents, cap analogs, and related oligo synthesis inputs.

How this supports a project

Material selection starts with the exact strand architecture and synthesis cycle. Monomer identity, protecting groups, solid support, coupling activation, oxidation or sulfurization, capping, cleavage, deprotection, purification, and analysis must be compatible as one workflow.

Start with the complete strand and synthesis conditions

In phosphoramidite solid-phase synthesis, repeated detritylation, coupling, oxidation or sulfurization, and capping steps extend a support-bound strand. The required phosphoramidites, support or linker, reagents, and final treatment depend on whether the target is DNA, RNA, a mixed or backbone-modified oligonucleotide, or a strand carrying internal or terminal functional groups.

A modified monomer is not defined only by its nucleobase or sugar modification. Phosphoramidite position, base and hydroxyl protecting groups, stereochemical form, counterion or solvent content, purity, storage, activation conditions, coupling time, and deprotection compatibility can affect incorporation and related impurities. Compatibility must be demonstrated in the intended sequence and cycle rather than inferred from structure alone.

Typical material and chemistry review workflow

1

Define the strand architecture

Provide the sequence, DNA or RNA character, every sugar and base modification, backbone linkage pattern, 3′ and 5′ termini, internal handles, and any conjugation or labeling site.

2

Map monomers and solid support

Match each protected phosphoramidite to its position and choose a support or support-bound linker that gives the required 3′ terminus and is compatible with cleavage.

3

Check the synthesis cycle

Review detritylation, activation, coupling time and equivalents, capping, oxidation or sulfurization, washing, reagent water sensitivity, and compatibility of modified residues with repeated cycles.

4

Plan cleavage and deprotection

Confirm how base, phosphate, sugar, linker, and terminal protecting groups are removed without unacceptable strand cleavage, desulfurization, elimination, isomerization, or damage to sensitive handles.

5

Define purification and analytical controls

Plan separation of failure sequences, incompletely deprotected material, phosphate/phosphorothioate variants, isomers, adducts, residual reagents, and other route-related species.

6

Confirm material performance in context

Evaluate incorporation, crude profile, full-length recovery, identity, purity, and specified impurities in a representative strand before assuming transfer to a different sequence or scale.

Inputs for route review

Sequence and modification map

Exact sequence with every modified nucleotide, backbone linkage, terminal group, spacer, branch, label, ligand, and attachment position marked.

Synthesis format

DNA or RNA chemistry, synthesizer or process format, scale, solid support and loading, activator, cycle conditions, oxidation or sulfurization reagent, and expected coupling time.

Cleavage and deprotection conditions

Reagents, temperature, time, order, any on-column treatment, and functional groups or linkages that must survive.

Material specification

Structure, stereochemical form, assay or purity method, water and solvent expectations, reactive content where relevant, storage, packaging, and required documentation.

Finished-strand analytical plan

Mass identity, purity or full-length content, sequence confirmation where required, phosphodiester or phosphorothioate pattern, specified impurities, residuals, and conjugate confirmation.

Project boundary

This capability covers selection and agreed project work for modified nucleosides and phosphoramidites, solid-support or linker inputs, sulfurizing reagents, cap-related materials, and other defined synthesis inputs. It does not imply availability of every monomer, support, sequence, protecting-group system, synthesis platform, scale, or finished oligonucleotide service. It also does not guarantee coupling efficiency, full-length yield, purity, stereochemical outcome, biological performance, stability, or regulatory status. Project scope is confirmed from the exact construct and process conditions.

Related catalog and technical pages

Sources

  1. 1.Deoxynucleoside phosphoramidites—A new class of key intermediates for deoxypolynucleotide synthesis (Tetrahedron Letters, 1981)
  2. 2.Synthesis of deoxyoligonucleotides on a polymer support (Journal of the American Chemical Society, 1981)
  3. 3.New nucleoside phosphoramidites and coupling protocols for solid-phase RNA synthesis (The Journal of Organic Chemistry, 1991)
  4. 4.Phosphorothioate Oligonucleotides with Low Phosphate Diester Content: Greater than 99.9% Sulfurization Efficiency with Aged Solutions of PADS (Organic Process Research & Development, 2004)